03Awarded Grand Prize in the Hair Category at Cosmoprof Worldwide Bologna
History
소니메디는 첨단 바이오 기술 기반의 ODM 기업
2025
03Signed a National HRD Consortium Agreement with the Korea National Enterprise for Clinical Trials (KoNECT)
02Registered a domestic patent for “Method of Producing Lactoferrin Derivatives”
02 Certified as a Technology-Innovation-Oriented SME (AA Grade)
01 Registered as a Family Company with Incheon National University
01 Signed a National Human Resources Development Consortium Agreement with Incheon Technopark (Design Education Center)
2024
12Awarded a Commendation from Incheon Metropolitan City for excellence in work-life balance
12Selected as an Excellent Work-Life Balance Company (by the Ministry of Employment and Labor & the Korea Chamber of Commerce and Industry)
11Signed an agreement under the IPP Work-Study Dual Training Consortium
10Certified as an Official Venture Company
10Recognized as a Talent-Nurturing SME by the Korean government
08Acquired ISO 45001 Occupational Health and Safety Management Certification
08Established a large-scale production line for egg embryonic stem cell-derived exosomes
06Development of sh-Polypeptide-153(E2F1) new material and registration for the first in world with INCI
05Certification for ISO22716 was obtained in May (renewal)
03Development of Tranexamoyl Dipeptide-35 new material and registration with INCI
05Selection of an SME by the Ministry of Employment and Labor in May
2023
12Certification for ISO 14001 was obtained in June
12In November, the development of Tranexamoyl Dipeptide-33 new material and registration with INCI
11Certification for Management Innovation SME in June (renewal)
06Redesignation as Promising Export Company
04Designation of the Global Strong SME 1,000+
02Certification as Intellectual Property Management
2022
12Fommendation from the Prime Minister
12Recognition as a Company Friendly to Women in Incheon
06Development of sh-Polypeptide-120(E2F4) new material and registration for the first in world with INCI
06Selection of an Outstanding Company for Job Invention Compensation
02Designation as a SME with Technological Innovation Focus
2021
12Development of Furfuralmethyl Citrate (Mumefural) new material and registration with INCI
07Certification for a ISO 9001:2006 was obtained (renewal)
07Redesignation as a Promising Export Company
06Development of N-Hyaluronoyl Lactoferrin new material and registration with INCI
03Designation as IP Star Enterprise
2020
11Certification for Promising SME Designation (Incheon Metropolitan City)
2019
12The development of Sakuranetin new material and registration with INCI
12The development of sr-(Melittin sh-Oligopeptide-1) new material and registration with INCI
11LMO Research Facility Confirmation by Ministry of Science and ICT
09Certification for a Product-Specific Approved Exporter
07Designation as Promising Export Company
05Relocation of SONIMEDI’s Manufacturing and R&D Center to Incheon Metropolitan
02Certification for INNOBiz
01Patent No. 10-1943302 Skin external application composition and cosmetic composition comprising ellagic acid and dihydromyricetin
2018
12Development of Tranexamoyl Tetrapeptide-51 new material and registration with INCI
12Development of Abietoyl Dipeptide-22 new material and registration with INCI
12Designation as SME with Outstanding employee development programs
05Certification for ISO22716 was obtained
2017
12Development of Passiflora Edulis Callus Culture Conditioned Media new material and registration with INCI
12development of Camellia Sinensis Callus Culture Conditioned Media new material and registration with INCI
10Development of Bambusa Vulgaris Callus Culture Conditioned Media new material and registration with INCI
07Development of Chicken Pluripotent Primordial Germ Cell Conditioned Media new material and registration For the first in the world with INCI
07Development of Chicken Embryonic Fibroblast Conditioned Media new material and registration For the first in the world with INCI
02Development of Turtle Embryonic Fibroblast Conditioned Media new material and registration For the first in the world with INCI
2016
12Development of Passiflora Edulis Meristem Cell Extract new material and registration with INCI
12Development of Red Junglefowl Induced Pluripotent Cell Culture Conditioned Media new material and Registration for the first in the world with INCI
10Development of Turtle Embryonic Fibroblast Conditioned Media new material and registration For the first in the world with INCI
09Opening the fourth OVACO Local Shop in Gwanggyo
05Development of Lactobacillus/Milt Ferment Filtrate new material and registration with INCI
05Development of Lactobacillus/Glucose/Milt Ferment Filtrate new material and registration with INCI
06 Certification for ISO 9001:2006 was obtained
07Development of Red Junglefowl Blastoderm Pluripotent Cell Culture Conditioned Media new material and registration for the first in the world with INCI
02Development of Hydrolyzed Milt Extract new material and registration with INCI
2015
12Development of Muscone new material and registration with INCI
12Development of Biotinoyl Tetrapeptide-51 new material and registration with INCI
11Development of Tetrapeptide-51 new material and registration with INCI
11Development of Hydrolyzed Fibroin new material and registration with INCI
10INCI Registration of Heptacodium miconioides Leaf Extract
10NCI Registration of Heptacodium miconioides Flower Extract
10Patent No. 10-1496557 Pharmaceutical composition for preventing or treating atopic dermatitis comprising extract of Sanguisorba officinalis and Hericium erinaceus
2014
Research and Development of Naflex™ 12 by Oriental Medicine Life Science Research Institute
Research and Development of Naflex™ 11 by Oriental Medicine Life Science Research Institute
2013
Certification for SMEs with Korea Agro-Fisheries & Food Trade Corporation
Patent No. 10-1252107 Composition for the prevention or treatment of atopic dermatitis containing herbal
Registration of cosmetics manufacturing and sales operations
Certification as a corporate-affiliated research institute
Collaborative Research and Development of Naflex™ 6 with Sangji University
2012
Establishment of Bio Cell Fusion Science Institute
Patent No. 10-1167285 Niacin-Peptides Having Skin Whitening Effect and Uses Therof
Patent No. 10-1127235 Ultrasound assisted extractor for decoction of natural product
Collaborative Research and Development of Naflex™ 10 with Ubo Hanuiwon Clinic
2011
Research and Development of Naflex™ 3 by Oriental Medicine Life Science Research Institute
Patent No. 10-1034405 Antibiotic Composition Containing Herbal Medicine Extracts
Patent No. 10-1032685 Composition for anti-obesity
Certification of Venture Enterprises
2010
Collaborative Research and Development of Naflex™ 1 with Korea Institute of Oriental Medicine
Collaborative Research and Development of Naflex™ 5 with Hoseo University
Registration of a manufactory in Wonju city, Gangwon State
2009
Collaborative Research and Development of Naflex™ 8 with Busan National University Granduate of Oriental Medicine
2008
Collaborative Research and Development of Naflex™ 8 with Busan National University Granduate of Oriental Medicine
Establishment of SONIMEDI Co.[Oriental Medicine Life Science Research Institute]
2007
Patent No. 10-0788306 for Original Far-Infrared Ultrasonic Extraction Method (FIU-T)
견적문의
비즈니스 상담